See also this year's filing and all EDGAR filings for this company.
PDF Report 0001335105_2023_Lixte_Biotechnology_Holdings_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001335105, Lixte Biotechnology Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,560,013 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 394,786 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,653,225 |
| 9 | ResearchAndDevelopmentExpense | 1,322,064 |
| 10 | remainder_Expenses | 2,356,559 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,957 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,560,013 |
| 1 | Liabilities | 394,786 |
| 2 | Expenses | 6,331,848 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 5,165,227 |
| 5 | NetIncome | -6,326,891 |
| 6 | ComprehensiveNetIncome | -6,326,891 |
| 7 | BaseVar | 6,145,802 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.66 |
| 9 | EconomicCapitalRatio | 2.79 |
Edgar->Model Mapping
Feature Distribution
Change over Time
